France· FR:63383409
URISPAS 200 mg, comprimé pelliculé
A medicinal product containing flavoxate (chlorhydrate de), registered in France by BOUCHARA-RECORDATI, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FLAVOXATE (CHLORHYDRATE DE)
- Manufacturer
- BOUCHARA-RECORDATI
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400932634095plaquette(s) thermoformée(s) PVC-Aluminium de 42 comprimé(s)EUR 4.96
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flavoxate (chlorhydrate de) in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandUrispas, FilmtablettenRECORDATI AG
- SpainURONID 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULACasen Recordati S.L.
- IrelandUrispas 200 mg Film-coated TabletsRecordati Ireland Limited
- United KingdomFlavoxate 100mg/5ml oral solutionSpecial Order
- United StatesFlavoxate HydrochlorideEpic Pharma, LLC
- GermanySpasuret 200 MgRecordati Pharma Gmbh
- NetherlandsUrispas, omhulde tabletten 200 mgRecordati Ireland Ltd. (Co. Cork)
- BelgiumUrispas 200 mgRecordati Ireland
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Urispas
- Germany · Spasuret 200 Mg
- Spain · Uronid
- United Kingdom (Northern Ireland) · Urispas
- Ireland · Urispas
- Italy · Genurin
- Lithuania · Urispas
- Luxembourg · Urispas
- Netherlands · Urispas
- Portugal · Urispás
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/150b4c9c-8408-44ff-ae25-6b86c3391f1a GET /v1/drugs/150b4c9c-8408-44ff-ae25-6b86c3391f1a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63383409",
"date_amm": "1981-04-28",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "FLAVOXATE (CHLORHYDRATE DE)",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about flavoxate (chlorhydrate de).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.